No evidence for alteration in early secondary mineralization by either alendronate, teriparatide or combination of both in transiliac bone biopsy samples from postmenopausal osteoporotic patients

The influence of treatment with alendronate (ALN), teriparatide (TPTD) or concurrent treatment with both on the human bone matrix mineralization has not yet been fully elucidated. For this purpose we analyzed quadruple fluorochrome labelled transiliac bone biopsy samples (n = 66) from postmenopausal...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Bone Rep
Hoofdauteurs: Misof, Barbara M., Roschger, Paul, Zhou, Hua, Nieves, Jeri W., Bostrom, Mathias, Cosman, Felicia, Lindsay, Robert, Klaushofer, Klaus, Dempster, David W.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Elsevier 2020
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7090359/
https://ncbi.nlm.nih.gov/pubmed/32215284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bonr.2020.100253
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items